Removal of the neurotransmitter norepinephrine from the space outside cells plays an important role in the regulation of bone remodeling.

Tacrolimus is essential for patients receiving new hearts, kidneys and other organ transplants. The drug suppresses the body’s immune system, helping to prevent rejection.

Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks.

Since it was founded in 1963, the Vanderbilt Division of Clinical Pharmacology has pioneered “translational science” and continues to transform medical practice worldwide, speakers at the division’s 50th anniversary scientific symposium said last week.

The 50th anniversary of the Division of Clinical Pharmacology will be celebrated Thursday, June 6, with a daylong scientific symposium and luncheon in the Student Life Center.

Dan Roden, M.D., assistant vice chancellor for Personalized Medicine and William Stokes Professor of Experimental Therapeutics, received a 2012 Distinguished Scientist Award at the annual Scientific Sessions of the American Heart Association (AHA) last week in Los Angeles.

Vanderbilt University’s Clinical and Translational Research Studio program has won the Award with Distinction for Innovations in Research Training and Education from the Association of American Medical Colleges (AAMC).